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The Synthesis of Prothrombin from Its
Precursor Protein
C. Vermeer, H.C. Hemker and B.A.M. Soute
Department of Biochemistry, Biomedical Centre, State University Limburg, Maastricht
Introduction
The absence of vitamin K induces the generation of new proteins (decar-
boxyproteins) in human and bovine blood (l) instead of the clotting factors II,
VII, IX, and X. These decarboxyproteins are immunologically identical to their
respective corresponding clotting factors but lack their functional activity.
After their discovery in 1963 (4) it lasted about 10 years before Fernlund et
al. (3) elucidated the difference between decarboxyproteins and the normal
clotting factors. It appeared that prothrombin (factor II) is decarboxypro-
thrombin with 10 of its glutamic acid residues (Glu) converted into 7-carboxy-
glutamic acid residues (Gla). The Gla residues give prothrombin its ability to
bind Ca2* and to act as the normal zymogen of thrombin.
Up to now, several authors showed that liver microsomes from vitamin K-
deficient rats mediate in the incorporation of l4C-labelled CO2 into a protein,
which is supposed to be an endogenous precursor of prothrombin and which
accumulates in the rat liver during vitamin K deficiency (l). Hence the ratliver
cell-free system contains both, the enzyme and the substrate. Obviously this
hampers further purification of the enzyme system.
Here we present evidence that separately purified decarboxyfactor II ob-
tained from coumarin-treated cows, can be converted into prothrombin by a
partly purified fraction from the microsomes of normal cow liver. The decar-
boxyfactor II converting enzyme system was called factor II synthetase, and was
defined as the activity that is able to decrease the one-stage clotting time
(factor II assay) of the reaction mixture during incubation at 37 'C. As will be
published elsewhere, this decrease of the clotting time is due to the conversion
of the added decarboxyfactor II into factor II.
The Synthesis of Prothrombin from lts Precursor Protein
Results and Discussion
Partial Purification of Foctor II Synthetase
Crude llver microsomes were prepared as described previously (7) and
supplemented with Triton X-100 to a final concentration of 2%. After centri-
fugation for I h at 150,0009 the supernatant was applied to a Sepharose 4-B
column. Two activity peaks were eluted from the column (fig. lA). The activity
present at the position of high molecular weight material was pooled, concen-
trated and applied for a second time to the same column. It appeared that most
of the activity had dissociated into the low molecular weight form (fig. I B). The
latter fractions were pooled, concentrated and used as semipurified factor II
synthetase.
Reaction Conditions Required for Factor II Synthesis
As already described (7), the synthesis of factor II depends on the tempera-
ture, the pH and the ionic conditions. Optima were found at 3'7 "C ,50 mM KCl,
IOmM tris-HCl and pH 7.8*8.5. When we investigated the dependence of the
reaction on cofactors such as vitamin K1 or HCO3 it appeared necessary to work
with limiting amounts of factor II synthetase. The best results were obtained
when the reaction velocity was about 3O% of its maximal value. When high
amounts of factor II synthetase were added to the incubation mixture, the
reaction was hardly dependent on any cofactor. This can be explained by the
fact that the factor Il-synthesizingenzyme is prepared from normal healthy cow
livers in which factor II synthesis is at its height. It seems probable that in an
enzyme system of this type all kinds of intermediates are present in which
vitamin K and/or HCO3 are already fixed somewhere in the efizyme that has just
been stopped from synthesizing factor II by our isolation procedure and not
(like in the rat system) by vitamin K deficiency of the intact animals.
High amounts of synthetase would include sufficient cofactors for a normal
reaction velocity. After about t h the reaction is then not inhibited by a
shortage of some cofactor but by the reaction product (see below). In this way
we found that the reaction components that are absolutely required for factor II
synthesis are: decarboxyfactor II and semipurified factor II synthetase. The
amount of factor II synthesized in 1|, h was hardly stimulated by adding
vitamin K1 (see table I). However, when the vitamin K antagonist warfarin
(5 nX,I) was added instead of vitamin K1 , the synthesis of factor II was blocked.
Only a residual synthetase activity occurred in the first 10min and the system
could be partially reactivated by adding vitamin K1 . This means that vitamin K is
probably present in our partly purified enzyme preparation and that its presence
is important for the function of factor II synthetase.
Furthermore, the reaction also needs molecular oxygen. The amount of
oxygen, that is normally dissolved in our buffers, is enough to give a normal
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Fig. 1. The partial purification of factorll synthetase. / Crude microsomes were
solubilized and centrifuged (see text) and 5 ml of the supernatant were applied to a
Sepharose 4-B column (2t12 x 100 cm) in buffer A (50 mM KCl, 10 mM Tris-HCl, pH 7.8).
Fractions of 90 drops were collected, and assayed by adding 50 pl of each fraction to 50 pl
of a mixture containing 2 mM NaHCO 3, 0.2 mM vitamin K, and 0.8 U/ml of purified
decarboxyfactor II (8) in buffer A. These mixtures were incubated at 37 'C for 1t/, h and
subsequently diluted 4 times with cold buffer A. The diluted mixtures were assayed in the
one-stage factor II assay (6) and the difference in the clotting time between incubated and
nonincubated mixtures was used to measure the amount of factor II synthesized during the
reaction. The clotting time of nonincubated mixtures (about 200 sec) is brought about by
the prothrombin actMty of decarboxyfactor II (8). After incubation the clotting times of
active fractions were about 50 sec. -B The first peak, containing high molecular weight
material was applied h second time on the same column. The synthetase activity appeared to
be partidlly dissociated into the low molecular weight form. Fractions containing the low
molecular weight synthetase activity were pooled and used as semipurified factor II synthe-
tase. The purification was about 10,000-fold.
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Table I. The influence of several reaction components on factor II synthetase; the reaction
mixtures contained 0.4 U/m1 of decarboxyfactor II and 0.01 ODrso units of factor II
synthetase in buffer A; incubation was performed at 37 "C for I t/, h
Addition to reaction mixture Atmosphere Prothrombin
synthesized, U/ml
None
Vitamin K1 (0.1 mM)
Warfarin (5 rnll4)
Vitamin Kr (0.1 mlf) + warfarin (5 d'|tr)
Glucose (0.5 tM
Glucose oxydase (0.5 mg/ml)
Glucose (0.5 nin4 + glucose oxydase (0.5 mg/ml)
Glucose (0.5 mM) + glucose oxydase (0.5 mg/ml)
Glucose (5 nIt'I) + glucose oxydase (0.5 mg/ml)
NaHCO. (L nM)
o2
o2
o2
o2
N 2
N 2
N 2
o2
oi
o2
or N,
0 .31
0.033
0.003
0.015
0,030
0.031
0.009
0.024
0
0.30
reaction velocity so the only way to demonstrate the oxygen dependency of the
reaction is to introduce an oxygen-consuming enzyme system (like glucose/
glucose oxydase) in our buffers and protein solutions and to remove all dissolved
oxygen prior to prothrombin synthesis. When a critical amount of glucose is
added, the reaction becomes absolutely dependent on the presence of oxygen in
the gasphase (table l).
Finally, we investigated the role of bicarbonate ions in the synthesis of
factor II. As the only difference between decarboxyfactor II and factor II is the
presence of l0 extra carboxyl groups in factor II, a carboxylation of our
decarboxyfactor II should take place, although we did not observe any depen-
dency of the reaction on added NaHCO3 (table I). Yet the rat system is able to
use HCO3 for its carboxylation of prothrombin precursor (2). We realized that
like oxygen, also C02 might be dissolved in our buffers to a sufficient extent for
a normal reaction velocity. Therefore, we added toc-labelled NaHCO3 to reac-
tion mixtures which werc analyzed on Sephadex G-100 columns after the
reaction had been completed. In this way we observed that the increase of
factor II activity occurs in parallel with the incorporation of r4CO, into protein
(fig. 2). Both, the newly formed factor II activity and the toc label were eluted
at the same position as nonconverted decarboxyfactor II, namely with a maxi
mum at fraction 15. This demonstrates that the molecular weight of the reaction
product is similar to that of decarboxyfactor II and factor II and strongly
suggests that also in the bovine system the incorporation ofcarboxyl groups into
decarboxyfactor II transforms the latter into factor II.
Other cofactors, such as ATP, NADH or dithiothreitol (DTT) did not
stimulate the synthesis of factor II. This is in contrast to earlier experiments (7)
Vermeer/Hemker/Soute
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Fig.2. Fractionation of reaction mixtures after factor II synthesis. Three reaction
mixtures (1 ml) containing either decarboxyfactor II (0.4 U/ml, experiment a), or synthe-
tase (0.01 ODrro units, experiment b) or a combination thereof (experiment c) were
incubated at the conditions described in the legend to figure 1, except that unlabelled HCO;
was replaced by 50 g.Ci NaHroCO, (60 mCi/mmol). After incubation the reaction mixtures
were dialyzed against buffer A for 2 h with two changes of the buffer. Subsequently they
were applied to a Sephadex G-100 column (1 X 40 cm) in buffer A. Fractions of 20 drops
were collected and analyzed for the presence of decarboxyfactor II (Echis Carinatus assay,
see ref. 6), factor II (one-stage coagulation assay) and '"C-label. * = Decarboxyfactor II
(experiments a and c); * = factor II (experiment a); * = factor II (experiment c);o = dpm/ml
(experiment a); o = dpm/ml (experiment c). The fraction of experiment b did not contain
any radioactivity.
in which we used crude microsomes instead of the semipurified enzyme. Similar
observations were reported by Esmon and Suttie (2), who found ATP-dependent
factor II synthesis in crude microsomes but ATP-independent factor II synthesis
in the soluble system. However, on other points such as the dependencyof the
reaction on NADH and reducing agents (DTT) our bovine system differs from
that of Esmon and Suttie (2) and is more similar to that described by Lowenthd
and Jaeger (5).
Feedback Inhibition of hothrombin Synthesis
As is shown in figure 3A, a time curve of prothrombin synthesis is straight
during the first minutes, but then it gradually flattens and after about 5% of all
decarboxyfactor II is consumed, no further conversion of decarboxyfactor II
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TIME, min
Frg 3. Time murse of prothrombin synthesis..4 The generation of factor II activity in
normal reaction mixtures (see the legend to figure 1, e) and in reaction mixtures to which
0.1 U/ml of factor II is added 30 min (*) or 85 min (*) after the start of the reaction. B The
incorporation of taCO, into BaSOo-adsorbable proteins. Normal reaction mixtures as
described in the legend to figure 2 (o), reaction mixtures containing 0.1 U/ml of factor II
(*), or mixtures in which vitamin K, is replaced by 5 mM of warfarin (*; were incubated at
37 'C. After the indicated time they were diluted with 10 ml of a solution containing
10 mll NaHCO3, pH 7.8 and adsorbed onto BaSOo (20 mg). The BaSOu was washed three
times with the bicarbonate solution and each time removed by centrifugation. Finally, the
BaSOo was suspended in Aquasol-2 (NEN) and counted as such.
into factor II is observed. It might be that one of the reaction components has
run out. Addition of more synthetase, however, does not lead to more pro-
thrombin synthesis. Therefore, we added purified factor II to reaction mixtures
before or during the incubation. In this way it proved that the reaction could
be stopped immediately at any stage of prothrombin synthesis by adding
0.1 U/ml of purified factor II. So it is very probable that the synthesis of
factor II in normal reaction mixtures stops, because a certain irmount of factor II
is synthesized. The reaction can only be started again by adding more decar-
boxyfactor II. Also when we studied the incorporation of laCO, we observed
this inhibition of the reaction by factor II (fig. 3B).
,/
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Without doubts more details of the reaction mechanism of the conversion of
decarboxyfactor II into factor II remain to be unraveled. For this kind of
research the bovine synthetase enzyme system provides good possibilities, where
other systems (rat) fail. This is because only in the bovine system it is possible to
separate the enzyme (synthetase) from its substrate (decarboxyfactor II). The
high degree of purification of bovine synthetase (about 10,000-fold) is a second
advantage of our system. Obviously the final purification of the enzyme is
required before the reaction mechanism can be studied in more detail.
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